MCID in their MG-ADL with a mean >4 point improvement in MG-ADL observed in Phase 1 study of Subcutaneous BRIUMVI ...
Knowable Magazine reports on a revolutionary CAR T-cell therapy, originally for cancer, now showing promise for autoimmune ...
Some early signs of MS can look like tiredness, but there are other subtle signs that should make one cautious, shares Dr Atampreet Singh. | Health ...
Alzheimer’s disease is the most common cause of dementia. In the United States, an estimated 6.9 million adults age 65 and ...
Abstract: Battery fault early warning is essential for the safe operation of electric vehicles, yet early-stage faults remain highly concealed and difficult to detect. While traditional threshold ...
Irisin, a hormone released during exercise, appears to directly shield neurons from damage in a mouse model of multiple ...
Pharmacokinetic and pharmacodynamic data support quarterly subcutaneous BRIUMVI dosing regimen currently under evaluation in fully enrolled Phase 3 trial; Top-line Phase 3 data expected year-end 2026 ...
A new study has revealed a group of blood proteins that are altered in people who go on to develop multiple sclerosis (MS), in some cases more than a decade before diagnosis. The findings offer hope ...
Multiple Sclerosis often goes unnoticed in India, with subtle symptoms like tingling or blurred vision dismissed as stress.
On World Multiple Sclerosis Day be warned hat blurred vision and eye pain may be early signs of the undiagnosed neurological ...
A major international phase III clinical trial, led by Queen Mary University of London, has found that ocrelizumab – a ...
Pierre Deny played Louis de Léon in the third and fourth series of Emily In Paris and had a 'sudden and severe case of ALS' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results